Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Degree

Medical Specialty

Submit

JAK Inhibitors in RA: Applying Evidence-Based Strategies in Clinical Decision-making

Source: JAK Inhibitors in RA: Applying Evidence-Based Strategies in Clinical Decision-making

Experts discuss the evidence-based application of recent efficacy and safety data for JAK inhibitors in RA to equip healthcare professionals in helping patients attain low disease activity/remission and improved quality of life.

Stanley B. Cohen, MD

Janet Pope, MD, MPH, FRCPC

Released: January 10, 2023 Expiration: No longer available for credit

Welcome to the CCO Site

JAK Inhibitors in RA: Applying Evidence-Based Strategies in Clinical Decision-making

Leaving the CCO site